SomaLogic partners with Dante Genomics On Clinical Research Adoption Of Proteomics In Europe
Portfolio Pulse from Benzinga Newsdesk
SomaLogic has partnered with Dante Genomics to promote the adoption of proteomics in clinical research across Europe. The partnership aims to leverage SomaLogic's SomaScan platform to provide proteomic data for Dante's genomic services.
July 24, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SomaLogic's partnership with Dante Genomics could potentially increase the adoption of its SomaScan platform in Europe, potentially leading to increased revenues.
The partnership with Dante Genomics could increase the adoption of SomaLogic's SomaScan platform in Europe. This could potentially lead to increased revenues for SomaLogic, which would likely have a positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100